General Surgery Department of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Iron Metabolism and Chelation Program, Department of Pathology, Bosch Institute, University of Sydney, New South Wales 2006, Australia.
Iron Metabolism and Chelation Program, Department of Pathology, Bosch Institute, University of Sydney, New South Wales 2006, Australia.
J Biol Chem. 2012 May 18;287(21):17016-17028. doi: 10.1074/jbc.M112.350470. Epub 2012 Mar 27.
The epithelial-mesenchymal transition (EMT) is a key step for cancer cell migration, invasion, and metastasis. Transforming growth factor-β (TGF-β) regulates the EMT and the metastasis suppressor gene, N-myc downstream-regulated gene-1 (NDRG1), could play a role in regulating the TGF-β pathway. NDRG1 expression is markedly increased after chelator-mediated iron depletion via hypoxia-inducible factor 1α-dependent and independent pathways (Le, N. T. and Richardson, D. R. (2004) Blood 104, 2967-2975). Moreover, novel iron chelators show marked and selective anti-tumor activity and are a potential new class of anti-metabolites. Considering this, the current study investigated the relationship between NDRG1 and the EMT to examine if iron chelators can inhibit the EMT via NDRG1 up-regulation. We demonstrated that TGF-β induces the EMT in HT29 and DU145 cells. Further, the chelators, desferrioxamine (DFO) and di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), inhibited the TGF-β-induced EMT by maintaining E-cadherin and β-catenin, at the cell membrane. We then established stable clones with NDRG1 overexpression and knock-down in HT29 and DU145 cells. These data showed that NDRG1 overexpression maintained membrane E-cadherin and β-catenin and inhibited TGF-β-stimulated cell migration and invasion. Conversely, NDRG1 knock-down caused morphological changes from an epithelial- to fibroblastic-like phenotype and also increased migration and invasion, demonstrating NDRG1 knockdown induced the EMT and enhanced TGF-β effects. We also investigated the mechanisms involved and showed the TGF-β/SMAD and Wnt pathways were implicated in NDRG1 regulation of E-cadherin and β-catenin expression and translocation. This study demonstrates that chelators inhibit the TGF-β-induced EMT via a process consistent with NDRG1 up-regulation and elucidates the mechanism of their activity.
上皮-间质转化(EMT)是癌细胞迁移、侵袭和转移的关键步骤。转化生长因子-β(TGF-β)调控 EMT,而抑癌基因 N- myc 下游调节基因 1(NDRG1)可在调控 TGF-β 通路方面发挥作用。通过缺氧诱导因子 1α 依赖性和非依赖性途径,螯合剂介导的铁耗竭后 NDRG1 的表达明显增加(Le,NT 和 Richardson,DR(2004)Blood 104,2967-2975)。此外,新型铁螯合剂具有显著的、选择性的抗肿瘤活性,是一类有潜力的新型抗代谢物。有鉴于此,本研究探讨了 NDRG1 与 EMT 之间的关系,以检验铁螯合剂是否能通过 NDRG1 的上调来抑制 EMT。我们证实 TGF-β 在 HT29 和 DU145 细胞中诱导 EMT。此外,螯合剂去铁胺(DFO)和二吡啶酮-4,4-二甲基-3-硫代缩氨基甲酸盐(Dp44mT)通过在细胞膜上维持 E-钙黏蛋白和β-连环蛋白来抑制 TGF-β 诱导的 EMT。然后,我们在 HT29 和 DU145 细胞中建立了 NDRG1 过表达和敲低的稳定克隆。这些数据表明,NDRG1 过表达维持了细胞膜上的 E-钙黏蛋白和β-连环蛋白,并抑制了 TGF-β 刺激的细胞迁移和侵袭。相反,NDRG1 敲低导致细胞形态从上皮样向成纤维样表型的变化,同时也增加了迁移和侵袭,表明 NDRG1 敲低诱导了 EMT 并增强了 TGF-β 的作用。我们还研究了涉及的机制,并表明 TGF-β/SMAD 和 Wnt 通路参与了 NDRG1 对 E-钙黏蛋白和β-连环蛋白表达和易位的调控。本研究表明,螯合剂通过与 NDRG1 上调一致的过程抑制 TGF-β 诱导的 EMT,并阐明了其活性的机制。